Lymphatic Endothelial C‐C Motif Chemokine Ligand 2 Enhances Lymphangiogenesis and Lymphatic Clearance of Macrophages Following Myocardial Infarction
Journal of the American Heart Association · 2026
DOI: 10.1161/jaha.124.039153 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Heart Association, 2026. Verfasst von Shengqiong Deng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Health Commission Key Lab of Artificial Intelligence (AI)-Based Management of Inflammation and Chronic Diseases, Department of Clinical Labo…. Hauptthemen laut MEDLINE: Lymphangiogenesis, Myocardial Infarction, Chemokine CCL2, Macrophages. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Inflammatory responses are crucial in the pathological cardiac remodeling and tissue repair after myocardial infarction (MI). The lymphatic endothelial cells (LECs) significantly influence immune cell clearance and mitigate cardiac inflammation. Chemokines are known to tightly regulate immune cell mobilization within the infarcted heart, affecting both inflammation and remodeling. However, the role of chemokines expressed by LECs in the regulation of cardiac inflammation post MI remains unclear. Our study aimed to investigate whether LEC‐expressing CCL2 (C‐C motif chemokine ligand 2) regulated post‐MI cardiac remodeling and its underlying molecular mechanisms.
Methods
We generated LEC‐conditional Ccl2 knockout mice and induced acute MI via left anterior descending coronary artery ligation in these mice. Cardiac function was assessed by echocardiography, and post‐MI remodeling was evaluated through serial histological analysis. Immunostaining was performed to examine lymphangiogenesis, macrophage infiltration, and macrophage clearance in the myocardium. Additionally, in vitro assays were conducted to investigate the role of LEC‐derived CCL2 in macrophage chemotaxis and lymphangiogenesis, including analyses of AKT/ETS1 (E26 oncogene homolog 1) signaling activation and VEGFC (vascular endothelial growth factor C) expression.
Results
Our results showed that the LEC‐ Ccl2 deficiency exacerbated cardiac dysfunction and worsened adverse cardiac remodeling after MI. Further immunostaining analysis showed that the loss of CCL2 in LECs impeded post‐MI lymphangiogenesis and increased macrophage infiltration in post‐MI myocardium and impaired macrophage clearance via afferent cardiac lymphatics. This led to exacerbated inflammatory responses and pathological cardiac remodeling after MI. In vitro studies identified that LEC‐derived CCL2 not only induced chemotaxis of macrophages but also activated AKT/ETS1 signaling, enhancing VEGFC expression and promoting lymphangiogenesis.
Conclusions
This study reveals that cardiac LEC‐expressing CCL2 tightly controls macrophage trafficking via lymphatic vessels in injured hearts and thus diminishes post‐MI inflammatory responses and lessens adverse cardiac remodeling. Our findings suggest that modulating CCL2 signaling in LECs could provide a promising therapeutic target for resolving excessive inflammation and ameliorating adverse cardiac remodeling after MI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shanghai Health Commission Key Lab of Artificial Intelligence (AI)-Based Management of Inflammation and Chronic Diseases, Department of Clinical Laboratory Gongli Hospital of Shanghai Pudong New Area Shanghai China.
- Gongli Hospital of Shanghai Pudong New Area Ningxia Medical University Ningxia China.
- School of Gongli Hospital Medical Technology University of Shanghai for Science and Technology Shanghai China.
- State Key Laboratory of Cardiovascular Diseases and Medical Innovation Center, Shanghai East Hospital, School of Medicine Tongji University Shanghai China.
- Department of Cardiology, Shanghai Children's Medical Center Shanghai Jiao Tong University School of Medicine Shanghai China.
- Department of Cardiology Zigong Fourth People's Hospital Zigong Sichuan China.
ORCID-Profile: Shengqiong Deng, Kang Zhao, Zeen Cai, Qinyu Li, Caixia Zhou, Yunhao Duan, Jinjin Wu, Lin Zhang, Yu Luo
Zitieren
APA
Deng, S., Zhao, K., Cai, Z., Li, Q., Li, S., Zhou, C., Duan, Y., Wu, J., Zhang, L., & Luo, Y. (2026). Lymphatic Endothelial C‐C Motif Chemokine Ligand 2 Enhances Lymphangiogenesis and Lymphatic Clearance of Macrophages Following Myocardial Infarction. Journal of the American Heart Association. https://doi.org/10.1161/jaha.124.039153
Vancouver
Deng S, Zhao K, Cai Z, Li Q, Li S, Zhou C, et al. Lymphatic Endothelial C‐C Motif Chemokine Ligand 2 Enhances Lymphangiogenesis and Lymphatic Clearance of Macrophages Following Myocardial Infarction. Journal of the American Heart Association. 2026. doi:10.1161/jaha.124.039153
BibTeX
@article{Deng2026,
author = {Deng, Shengqiong and Zhao, Kang and Cai, Zeen and Li, Qinyu and Li, Shan and Zhou, Caixia and Duan, Yunhao and Wu, Jinjin and Zhang, Lin and Luo, Yu},
title = {Lymphatic Endothelial C‐C Motif Chemokine Ligand 2 Enhances Lymphangiogenesis and Lymphatic Clearance of Macrophages Following Myocardial Infarction},
journal = {Journal of the American Heart Association},
year = {2026},
doi = {10.1161/jaha.124.039153}
}
EUVIMED